Compounds > daunorubicin
Page last updated: 2024-08-23

daunorubicin and Coronary Occlusion

daunorubicin has been researched along with Coronary Occlusion in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Cheng, B; Du, J; Fu, MH; Pan, YY; Tao, XF1
Fan, B; Ge, J; Ge, L; Lu, H; Ma, J; Qian, J; Zhong, X1

Other Studies

2 other study(ies) available for daunorubicin and Coronary Occlusion

ArticleYear
Safety and efficacy of a low frame rate protocol for percutaneous coronary intervention for chronic total occlusions.
    Chinese medical journal, 2021, Feb-23, Volume: 134, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Thioguanine; Treatment Outcome

2021
Safety and feasibility of a low frame rate protocol for percutaneous coronary intervention to chronic total occlusions: preliminary experience.
    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018, Aug-03, Volume: 14, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Coronary Angiography; Coronary Occlusion; Cytarabine; Daunorubicin; Feasibility Studies; Humans; Percutaneous Coronary Intervention; Podophyllotoxin; Registries; Thioguanine; Treatment Outcome

2018